Calif. voters lean toward stem cell measure-pol
By Reuters,
Reuters
| 09. 24. 2004
LOS ANGELES, Sept 23 (Reuters) - A majority of likely voters in California favor a ballot proposal that would authorize $3 billion in state bonds to fund controversial stem cell research, according to a poll released on Thursday.
The referendum, on the Nov. 2 ballot, would create the largest pool of public funding for such research in the United States at a time when the Bush administration has sharply curtailed spending on studies involving embryonic stem cells.
Backers of the initiative, including Hollywood celebrities and Silicon Valley billionaires, argue that such research could potentially lead to cures for diseases such as Parkinson's, Alzheimer's and diabetes.
A survey by the Los Angeles Times showed that while most voters had not yet formed an opinion on the ballot measure known as Proposition 71, a majority expressed support once they were read the proposal itself.
The survey showed 54 percent of likely voters in California said they were inclined to vote for the stem cell proposal, compared with 32 percent who said they would vote against it.
Fourteen percent said they were not...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...